Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 105,555 | 113,420 | 103,379 | 92,999 | 105,595 |
| Cost of Goods | 31,280 | 27,364 | 24,027 | 21,053 | 20,930 |
| Gross Profit | 74,275 | 86,056 | 79,352 | 71,946 | 84,665 |
| Operating Expenses | 52,806 | 40,691 | 28,772 | 23,865 | 24,148 |
| Operating Income | 21,749 | 45,729 | 50,607 | 48,134 | 61,447 |
| Other Income | 1,458 | 473 | 263 | 120 | 58 |
| Pre-tax Income | 23,207 | 46,202 | 50,870 | 48,254 | 61,505 |
| Income Tax | 4,485 | 14,386 | 18,323 | 17,496 | 23,186 |
| Net Income Continuous | 18,722 | 31,816 | 32,547 | 30,758 | 38,319 |
| Net Income | $18,722 | $31,816 | $32,547 | $30,758 | $38,319 |
| EPS Basic Total Ops | 1.30 | 2.18 | 2.22 | 2.06 | 2.61 |
| EPS Basic Continuous Ops | 1.30 | 2.18 | 2.22 | 2.06 | 2.61 |
| EPS Diluted Total Ops | 1.27 | 2.11 | 2.15 | 2.01 | 2.51 |
| EPS Diluted Continuous Ops | 1.27 | 2.11 | 2.15 | 2.01 | 2.51 |
| EPS Diluted Before Non-Recurring Items | 1.84 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $27,288 | $50,019 | $54,341 | $51,909 | $66,153 |